Vaccination against IL-33 inhibits airway hyperresponsiveness and inflammation in a house dust mite model of asthma

PLoS ONE

Volumn 10, Issue 7, 2015, Pages

  Lei, Ying ^a,d   Boinapally, Vamsi ^b   Zoltowska, Anna ^a   Adner, Mikael ^c   Hellman, Lars ^b   Nilsson, Gunnar ^a,c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

^d XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 25; INTERLEUKIN 33; INTERLEUKIN 33 VACCINE; NEUTRALIZING ANTIBODY; THYMIC STROMAL LYMPHOPOIETIN; UNCLASSIFIED DRUG; VACCINE; ANTIGEN; CYTOKINE; IMMUNOGLOBULIN G; IMMUNOLOGICAL ADJUVANT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; ASTHMA; BAGG ALBINO MOUSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DERMATOPHAGOIDES; EOSINOPHIL COUNT; FEMALE; INFLAMMATORY CELL; LEUKOCYTE MIGRATION; LUNG LAVAGE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT INFLAMMATION; TISSUE HOMOGENATE; VACCINATION; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; BRONCHOALVEOLAR LAVAGE FLUID; DISEASE MODEL; IMMUNOLOGY; INFLAMMATION; METABOLISM; PYROGLYPHIDAE;

ADJUVANTS, IMMUNOLOGIC; ALLERGENS; ANIMALS; ANTIGENS; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; DISEASE MODELS, ANIMAL; IMMUNOGLOBULIN G; INFLAMMATION; INTERLEUKIN-33; MICE; PYROGLYPHIDAE; RESPIRATORY HYPERSENSITIVITY; VACCINATION; VACCINES;

EID: 84941702891     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0133774     Document Type: Article

References (48)

1. Wenzel SE. Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med. 2012; 18(5): 716-25. PMID: 22561835. doi: 10.1038/nm.2678
2. Holgate ST. Epithelium dysfunction in asthma. The Journal of allergy and clinical immunology. 2007; 120(6): 1233-44; quiz 45-6. Epub 2007/12/13. doi: 10.1016/j.jaci.2007.10.025 PMID: 18073119.
3. Hellman L. Therapeutic vaccines against IgE-mediated allergies. Expert review of vaccines. 2008; 7 (2): 193-208. Epub 2008/03/08. doi: 10.1586/14760584.7.2.193 PMID: 18324889.
4. Holgate ST. Innate and adaptive immune responses in asthma. Nature medicine. 2012; 18(5): 673-83. Epub 2012/05/09. doi: 10.1038/nm.2731 PMID: 22561831.
5. Hellman L. Regulation of IgE homeostasis, and the identification of potential targets for therapeutic intervention. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2007; 61(1): 34-49. doi: 10.1016/j.biopha.2006.10.001 PMID: 17145160.
6. Moffatt MF, Gut IG, Demenais F, Strachan DP, Bouzigon E, Heath S, et al. A large-scale, consortiumbased genomewide association study of asthma. The New England journal of medicine. 2010; 363 (13): 1211-21. Epub 2010/09/24. doi: 10.1056/NEJMoa0906312 PMID: 20860503.
7. Reijmerink NE, Postma DS, Bruinenberg M, Nolte IM, Meyers DA, Bleecker ER, et al. Association of IL1RL1, IL18R1, and IL18RAP gene cluster polymorphisms with asthma and atopy. The Journal of allergy and clinical immunology. 2008; 122(3): 651-4 e8. Epub 2008/09/09. doi: 10.1016/j.jaci.2008.06. 030 PMID: 18774397.
8. Savenije OE, Mahachie John JM, Granell R, Kerkhof M, Dijk FN, de Jongste JC, et al. Association of IL33-IL-1 receptor-like 1 (IL1RL1) pathway polymorphisms with wheezing phenotypes and asthma in childhood. The Journal of allergy and clinical immunology. 2014. Epub 2014/02/27. doi: 10.1016/j.jaci. 2013.12.1080 PMID: 24568840.
9. Bonnelykke K, Sleiman P, Nielsen K, Kreiner-Moller E, Mercader JM, Belgrave D, et al. A genome-wide association study identifies CDHR3 as a susceptibility locus for early childhood asthma with severe exacerbations. Nat Genet. 2013; 46: 51-5. doi: 10.1038/ng.2830 PMID: 24241537.
10. Prefontaine D, Lajoie-Kadoch S, Foley S, Audusseau S, Olivenstein R, Halayko AJ, et al. Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells. Journal of immunology. 2009; 183(8): 5094-103. Epub 2009/10/06. doi: 10.4049/jimmunol.0802387 PMID: 19801525.
11. Prefontaine D, Nadigel J, Chouiali F, Audusseau S, Semlali A, Chakir J, et al. Increased IL-33 expression by epithelial cells in bronchial asthma. The Journal of allergy and clinical immunology. 2010; 125 (3): 752-4. Epub 2010/02/16. doi: 10.1016/j.jaci.2009.12.935 PMID: 20153038.
12. Fux M, Pecaric-Petkovic T, Odermatt A, Hausmann OV, Lorentz A, Bischoff SC, et al. IL-33 is a mediator rather than a trigger of the acute allergic response in humans. Allergy. 2013; 69: 216-22. doi: 10. 1111/all.12309 PMID: 24205920.
13. Kearley J, Buckland KF, Mathie SA, Lloyd CM. Resolution of allergic inflammation and airway hyperreactivity is dependent upon disruption of the T1/ST2-IL-33 pathway. American journal of respiratory and critical care medicine. 2009; 179(9): 772-81. Epub 2009/01/31. doi: 10.1164/rccm.200805-666OC PMID: 19179489; PubMed Central PMCID: PMC2675564.
14. Hammad H, Chieppa M, Perros F, Willart MA, Germain RN, Lambrecht BN. House dust mite allergen induces asthma via Toll-like receptor 4 triggering of airway structural cells. Nat Med. 2009; 15(4): 410-6. doi: 10.1038/nm.1946 PMID: 19330007; PubMed Central PMCID: PMC2789255.
15. Grotenboer NS, Ketelaar ME, Koppelman GH, Nawijn MC. Decoding asthma: translating genetic variation in IL33 and IL1RL1 into disease pathophysiology. The Journal of allergy and clinical immunology. 2013; 131(3): 856-65. Epub 2013/02/06. doi: 10.1016/j.jaci.2012.11.028 PMID: 23380221.
16. Johnson JR, Wiley RE, Fattouh R, Swirski FK, Gajewska BU, Coyle AJ, et al. Continuous exposure to house dust mite elicits chronic airway inflammation and structural remodeling. American journal of respiratory and critical care medicine. 2004; 169(3): 378-85. Epub 2003/11/05. doi: 10.1164/rccm. 200308-1094OC PMID: 14597485.
17. Ringvall M, Huijbers EJ, Ahooghalandari P, Alekseeva L, Andronova T, Olsson AK, et al. Identification of potent biodegradable adjuvants that efficiently break self-tolerance-A key issue in the development of therapeutic vaccines. Vaccine. 2009; 28(1): 48-52. Epub 2009/10/20. doi: 10.1016/j.vaccine.2009. 09.122 PMID: 19835827.
18. Swedin L, Ellis R, Kemi C, Ryrfeldt A, Inman M, Dahlen SE, et al. Comparison of aerosol and intranasal challenge in a mouse model of allergic airway inflammation and hyperresponsiveness. International archives of allergy and immunology. 2010; 153(3): 249-58. Epub 2010/05/21. doi: 10.1159/000314365 PMID: 20484923.
19. Fuchs B, Sjöberg L, Möller Westerberg C, Ekoff M, Swedin L, Dahlen SE, et al. Mast cell engraftment of the peripheral lung enhances airway hyperresponsiveness in a mouse asthma model. Am J Physiol Lung Cell Mol Physiol. 2012; 303: 1027-36. PMID: 23043076.
20. Saglani S, Mathie SA, Gregory LG, Bell MJ, Bush A, Lloyd CM. Pathophysiological features of asthma develop in parallel in house dust mite-exposed neonatal mice. American journal of respiratory cell and molecular biology. 2009; 41(3): 281-9. Epub 2009/01/20. doi: 10.1165/rcmb.2008-0396OC PMID: 19151316; PubMed Central PMCID: PMC3380517.
21. Townsend MJ, Fallon PG, Matthews DJ, Smith P, Jolin HE, McKenzie ANJ. IL-9-deficient mice establish fundamental roles for IL-9 in pulmonary mastocytosis and goblet cell hyperplasia but not T cell development. Immunity. 2000; 13: 573-83. PMID: 11070175
22. Huijbers EJ, Femel J, Andersson K, Bjorkelund H, Hellman L, Olsson AK. The non-toxic and biodegradable adjuvant Montanide ISA 720/CpG can replace Freund's in a cancer vaccine targeting ED-B-A prerequisite for clinical development. Vaccine. 2012; 30(2): 225-30. Epub 2011/11/15. doi: 10.1016/j. vaccine.2011.11.010 PMID: 22079080.
23. Huijbers EJ, Ringvall M, Femel J, Kalamajski S, Lukinius A, Abrink M, et al. Vaccination against the extra domain-B of fibronectin as a novel tumor therapy. FASEB journal: official publication of the Federation of American Societies for Experimental Biology. 2010; 24(11): 4535-44. Epub 2010/07/17. doi: 10.1096/fj.10-163022 PMID: 20634349.
24. Vernersson M, Ledin A, Johansson J, Hellman L. Generation of therapeutic antibody responses against IgE through vaccination. FASEB J. 2002; 16(8): 875-7. doi: 10.1096/fj.01-0879fje PMID: 11967231.
25. Nandakumar KS, Jansson A, Xu B, Rydell N, Ahooghalandari P, Hellman L, et al. A recombinant vaccine effectively induces c5a-specific neutralizing antibodies and prevents arthritis. PloS one. 2010; 5 (10): e13511. doi: 10.1371/journal.pone.0013511 PMID: 20975959; PubMed Central PMCID: PMC2958150.
26. Johansson J, Ledin A, Vernersson M, Lovgren-Bengtsson K, Hellman L. Identification of adjuvants that enhance the therapeutic antibody response to host IgE. Vaccine. 2004; 22(21-22): 2873-80. Epub 2004/07/13. doi: 10.1016/j.vaccine.2003.12.029 PMID: 15246623.
27. Johansson J, Hellman L. Modifications increasing the efficacy of recombinant vaccines; marked increase in antibody titers with moderately repetitive variants of a therapeutic allergy vaccine. Vaccine. 2007; 25(9): 1676-82. Epub 2006/12/08. doi: 10.1016/j.vaccine.2006.10.055 PMID: 17150285.
28. Makrinioti H, Toussaint M, Jackson DJ, Walton RP, Johnston SL. Role of interleukin 33 in respiratory allergy and asthma. The Lancet Respiratory medicine. 2014; 2(3): 226-37. Epub 2014/03/14. doi: 10. 1016/S2213-2600(13)70261-3 PMID: 24621684.
29. Borges MC, Marchica CL, Narayanan V, Ludwig MS. Allergen challenge during halothane compared to isoflurane anesthesia induces a more potent peripheral lung response. Respiratory physiology & neurobiology. 2013; 189(1): 144-52. Epub 2013/07/24. doi: 10.1016/j.resp.2013.07.005 PMID: 23876740.
30. Kim YH, Park CS, Lim DH, Ahn SH, Son BK, Kim JH, et al. Beneficial effect of anti-interleukin-33 on the murine model of allergic inflammation of the lower airway. The Journal of asthma: official journal of the Association for the Care of Asthma. 2012; 49(7): 738-43. Epub 2012/07/18. doi: 10.3109/02770903. 2012.702841 PMID: 22799279.
31. Mizutani N, Nabe T, Yoshino S. Interleukin-33 and alveolar macrophages contribute to the mechanisms underlying the exacerbation of IgE-mediated airway inflammation and remodelling in mice. Immunology. 2013; 139(2): 205-18. Epub 2013/01/18. doi: 10.1111/imm.12071 PMID: 23323935; PubMed Central PMCID: PMC3647187.
32. Chen ZG, Zhang TT, Li HT, Chen FH, Zou XL, Ji JZ, et al. Neutralization of TSLP inhibits airway remodeling in a murine model of allergic asthma induced by chronic exposure to house dust mite. PloS one. 2013; 8(1): e51268. Epub 2013/01/10. doi: 10.1371/journal.pone.0051268 PMID: 23300949; PubMed Central PMCID: PMC3534685.
33. Gregory LG, Jones CP, Walker SA, Sawant D, Gowers KH, Campbell GA, et al. IL-25 drives remodelling in allergic airways disease induced by house dust mite. Thorax. 2013; 68(1): 82-90. Epub 2012/10/25. doi: 10.1136/thoraxjnl-2012-202003 PMID: 23093652; PubMed Central PMCID: PMC3534261.
34. Silverpil E, Linden A. IL-17 in human asthma. Expert review of respiratory medicine. 2012; 6(2): 173-86. doi: 10.1586/ers.12.12 PMID: 22455490.
35. Guo L, Wei G, Zhu J, Liao W, Leonard WJ, Zhao K, et al. IL-1 family members and STAT activators induce cytokine production by Th2, Th17, and Th1 cells. Proceedings of the National Academy of Sciences of the United States of America. 2009; 106(32): 13463-8. Epub 2009/08/12. doi: 10.1073/pnas. 0906988106 PMID: 19666510; PubMed Central PMCID: PMC2726336.
36. Kabata H, Moro K, Fukunaga K, Suzuki Y, Miyata J, Masaki K, et al. Thymic stromal lymphopoietin induces corticosteroid resistance in natural helper cells during airway inflammation. Nature communications. 2013; 4: 2675. Epub 2013/10/26. doi: 10.1038/ncomms3675 PMID: 24157859.
37. Mizutani N, Nabe T, Yoshino S. IL-17A promotes the exacerbation of IL-33-induced airway hyperresponsiveness by enhancing neutrophilic inflammation via CXCR2 signaling in mice. Journal of immunology. 2014; 192(4): 1372-84. Epub 2014/01/22. doi: 10.4049/jimmunol.1301538 PMID: 24446518.
38. Daan de Boer J, Roelofs JJ, de Vos AF, de Beer R, Schouten M, Hommes TJ, et al. Lipopolysaccharide inhibits Th2 lung inflammation induced by house dust mite allergens in mice. American journal of respiratory cell and molecular biology. 2013; 48(3): 382-9. Epub 2012/12/15. doi: 10.1165/rcmb.2012-0331OC PMID: 23239494.
39. Lee HY, Rhee CK, Kang JY, Byun JH, Choi JY, Kim SJ, et al. Blockade of IL-33/ST2 ameliorates airway inflammation in a murine model of allergic asthma. Experimental lung research. 2014; 40(2): 66-76. Epub 2014/01/23. doi: 10.3109/01902148.2013.870261 PMID: 24446582.
40. Gregory LG, Causton B, Murdoch JR, Mathie SA, O'Donnell V, Thomas CP, et al. Inhaled house dust mite induces pulmonary T helper 2 cytokine production. Clinical and experimental allergy: journal of the British Society for Allergy and Clinical Immunology. 2009; 39(10): 1597-610. Epub 2009/06/24. doi: 10. 1111/j.1365-2222.2009.03302.x PMID: 19545261; PubMed Central PMCID: PMC3385347.
41. Besnard AG, Guabiraba R, Niedbala W, Palomo J, Reverchon F, Shaw TN, et al. IL-33-mediated protection against experimental cerebral malaria is linked to induction of type 2 innate lymphoid cells, M2 macrophages and regulatory T cells. PLoS pathogens. 2015; 11(2): e1004607. Epub 2015/02/07. doi: 10.1371/journal.ppat.1004607 PMID: 25659095.
42. Miller AM, Xu D, Asquith DL, Denby L, Li Y, Sattar N, et al. IL-33 reduces the development of atherosclerosis. The Journal of experimental medicine. 2008; 205(2): 339-46. Epub 2008/02/13. doi: 10.1084/jem.20071868 PMID: 18268038; PubMed Central PMCID: PMC2271006.
43. Volarevic V, Mitrovic M, Milovanovic M, Zelen I, Nikolic I, Mitrovic S, et al. Protective role of IL-33/ST2 axis in Con A-induced hepatitis. Journal of hepatology. 2012; 56(1): 26-33. Epub 2011/06/28. doi: 10. 1016/j.jhep.2011.03.022 PMID: 21703183.
44. Humphreys NE, Xu D, Hepworth MR, Liew FY, Grencis RK. IL-33, a potent inducer of adaptive immunity to intestinal nematodes. Journal of immunology. 2008; 180(4): 2443-9. Epub 2008/02/06. PMID: 18250453.
45. Sanada S, Hakuno D, Higgins LJ, Schreiter ER, McKenzie AN, Lee RT. IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system. The Journal of clinical investigation. 2007; 117(6): 1538-49. Epub 2007/05/12. doi: 10.1172/JCI30634 PMID: 17492053; PubMed Central PMCID: PMC1865027.
46. Brode SK, Jamieson FB, Ng R, Campitelli MA, Kwong JC, Paterson JM, et al. Increased risk of mycobacterial infections associated with anti-rheumatic medications. Thorax. 2015; 70(7): 677-82. Epub 2015/04/26. doi: 10.1136/thoraxjnl-2014-206470 PMID: 25911222.
47. Ford AC, Peyrin-Biroulet L. Opportunistic infections with anti-tumor necrosis factor-alpha therapy in inflammatory bowel disease: meta-analysis of randomized controlled trials. The American journal of gastroenterology. 2013; 108(8): 1268-76. Epub 2013/05/08. doi: 10.1038/ajg.2013.138 PMID: 23649185.
48. Sjoberg LC, Gregory JA, Dahlen SE, Nilsson GP, Adner M. Interleukin-33 exacerbates allergic bronchoconstriction in the mice via activation of mast cells. Allergy. 2015; 70(5): 514-21. Epub 2015/02/11. doi: 10.1111/all.12590 PMID: 25660244.